Business
Real Brands Signs Definitive Agreement for the Acquisition of Boulder Botanical & Biosciences Laboratories Assets
Real Brands Signs Definitive Agreement for the Acquisition of Boulder Botanical & Biosciences Laboratories Assets.
About this update from Real Brands, Inc.
[{"type":"text","content":"\n $12 million transactionProvides Real Brands with world class R&D and manufacturing capabilities for 300% increase in production capacity and 150+ brandsSpecializes in sports medicine, health and wellness herbal supplements and CBD productsExpands Real Brands’ distribution to major retail chains nationwide North Providence, RI, and Golden, CO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCQB: RLBD) announced today that it has signed the definitive agreement for the acquisition of substantially all the assets of Boulder Botanical & Biosciences Laboratories, Inc. (Boulder Botanical), a manufacturer of white-label and private-label wellness and sports medicine herbal supplements and CBD products, from Frankens Investment Fund, LLC, which had acquired Boulder Botanical in April 2022. The acquisition will include Boulder Botanical’s brands for human and pet markets, IP, and distribution at the 27,000 sq. ft. R&D and production facility in Golden, Colorado. The value of the transaction is $12 million, with a $1 million operating capital commitment. Boulder Botanical will retain its name and operate as a division of Real Brands. Thom Kidrin, President & CEO of Real Brands Inc., stated, “Boulder Botanical has had an excellent reputation for creating quality sports medicine, health and wellness herbal supplements and cannabinoid formulations and its white-label manufacturing services exceeding industry standards. We expect to build upon that solid foundation. Boulder Botanical’s existing national distribution network serving CVS, Target, Costco, and other retailers, combined with Real Brands’ expertise in online sales and the metaverse, enables ready access to millions of existing customers and millions more potential customers online and in person. With this acquisition, we have increased our production capacity by 300%, have added a portfolio of 150+ brands, extensive IP, and a skilled R&D team to create hundreds more products to meet the demand of the burgeoning herbal supplement and CBD markets.” The U.S. Herbal Supplements Market size was estimated at $2.2 billion in 2021, $2.6 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.62% to reach $4.1 billion by 2027, as forecast by ResearchandMarkets.com. ResearchandMarkets.com&#...